Morepen Laboratories Limited

Web: morepen.com NSE: MOREPENLAB BSE: 500288 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

44 0(1%)

Volume

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,408

No. of Shares

54.8

P/E

30.08

P/B

3.72

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.38

ROCE

Profit Growth

Listing Date

24-Nov-99

Promoter Holding

35.66%

FII Holding

1.59%

DII Holding

1.25%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Aug 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(-2.61) 35.66%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(1.51) 38.22%	(-1.61) 36.74%	(3.81) 38.38%	(0.01) 34.54%
FIIs	(0.01) 1.59%	(0.01) 1.62%	(-0.11) 1.62%	(-0.21) 1.72%	(-0.31) 1.94%	(0.11) 2.22%	(-5.61) 2.08%	(6.11) 7.72%	(-0.21) 1.67%	(-0.31) 1.85%	(0.81) 2.11%	(0.31) 1.29%	(0.01) 1.00%	(0.11) 0.96%	(-0.31) 0.89%	(0.21) 1.15%	(0.01) 0.95%	(0.01) 0.96%	(0.01) 0.91%
DIIs	(0.01) 1.25%	(-0.21) 1.25%	(0.01) 1.49%	(-0.21) 1.50%	(0.01) 1.67%	(-0.11) 1.64%	(-1.21) 1.69%	(0.71) 2.84%	(0.01) 2.14%	(-0.11) 2.15%	(-0.11) 2.21%	(0.01) 2.27%	(-0.61) 2.32%	(-0.81) 2.93%	(-0.21) 3.74%	(-0.11) 3.98%	(3.01) 4.08%	(-0.11) 1.07%	(0.01) 1.16%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%
Public	61.50%	61.46%	61.22%	61.09%	60.72%	60.46%	60.57%	53.77%	57.96%	57.76%	57.46%	58.20%	58.45%	57.88%	57.15%	56.63%	58.24%	59.59%	63.39%
No. of Shareholders	447,286	453,137	461,853	461,180	468,860	448,361	430,929	352,839	348,766	336,019	304,289	304,001	301,832	306,150	306,030	290,367	287,115	261,437	255,155

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	485	484	412	425	466	453	438	455	423	445	422	401	364	348	403	302	368	396	395	387
Expenses	460	438	381	401	424	417	394	404	375	394	388	375	348	328	374	288	350	364	353	343
Operating Profit	24	46	31	24	42	36	44	52	48	51	34	26	16	21	29	15	19	32	42	44
OPM %	5	10	7	6	9	8	10	11	11	11	8	7	4	6	7	5	5	8	11	11
Other Income	8	4	30	4	5	5	5	3	4	4	3	2	3	1	1	1	3	3	3	2
Interest	4	4	4	4	5	1	1	1	1	2	0	0	1	1	0	0	1	1	-9	0
Depreciation	6	10	11	9	16	5	2	6	10	8	8	8	7	7	7	7	7	7	7	7
Profit before tax	23	35	46	16	26	35	46	48	42	44	29	21	11	14	22	8	14	27	47	39
Tax %	33	22	10	26	21	24	24	25	32	27	26	29	26	36	29	32	13	21	20	21
Net Profit	16	28	41	11	20	27	35	36	29	32	21	15	8	9	16	6	12	22	37	30
EPS in Rs	0.29	0.5	0.75	0.2	0.37	0.49	0.64	0.71	0.55	0.63	0.42	0.29	0.16	0.18	0.31	0.11	0.26	0.48	0.83	0.68

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1806	1812	1690	1418	1547	1188	853	769	607	595	485	401	367	326
Expenses	1680	1638	1532	1338	1410	1070	785	701	542	534	424	352	318	295
Operating Profit	126	174	159	80	137	119	69	68	65	61	62	48	49	31
OPM %	7	10	9	6	9	10	8	9	11	10	13	12	13	10
Other Income	47	18	14	6	10	12	9	4	4	4	-3	1	4	6
Interest	16	8	4	2	-7	2	2	2	4	8	10	9	10	12
Depreciation	36	29	33	28	28	30	37	40	34	34	35	39	46	46
Profit before tax	120	155	135	56	127	99	39	29	30	24	13	2	-3	-21
Tax %	20	24	29	31	20	1	14	1	0	0	-1	6	0	0
Net Profit	96	118	97	39	102	97	34	29	30	24	13	2	-3	-21
EPS in Rs	1.73	2.15	1.88	0.76	2.13	2.16	0.75	0.64	0.66	0.53	0.28	0.05	-0.06	-0.46
Dividend Payout %	12	9	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	32	73	-91	-60	51	11	17	63	41	50	51	34	34
Cash from Investing Activity	-322	-83	-47	-32	-70	-12	-13	-27	-14	-27	-32	-1	-3
Cash from Financing Activity	300	5	144	66	47	5	0	-38	-24	-27	-19	-29	-30
Net Cash Flow	10	-5	6	-26	28	4	4	-1	3	-4	0	4	1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	110	110	110	110	102	102	96	90	90	90	90	90	90	90	90	90
Reserves	1137	1087	1047	1001	745	651	483	335	194	163	136	106	91	78	88	90
Borrowings	208	158	105	33	29	25	19	17	133	132	134	169	187	201	209	231
Other Liabilities	482	381	517	418	417	332	473	416	246	230	226	173	156	121	103	95
Total Liabilities	1936	1736	1778	1562	1293	1110	1070	858	663	615	586	538	524	489	490	506
Fixed Assets	513	471	489	355	307	267	252	225	216	236	264	272	297	322	368	409
CWIP	22	26	28	18	24	17	14	2	0	0	0	0	0	0	0	0
Investments	124	136	85	132	1	0	0	1	1	0	0	0	0	0	0	4
Other Assets	1277	1104	1176	1056	960	827	804	631	446	379	321	266	227	167	121	93
Total Assets	1936	1736	1778	1562	1293	1110	1070	858	663	615	586	538	524	489	490	506

Delivery

#	Date	33 42% 47	Value (Cr)	Q/T 319	Del 37	Del 9
1	27-May	42	31	417	40	13
2	26-May	44	20	289	35	7
3	25-May	44	10	315	43	4
4	22-May	43	17	279	27	5
5	21-May	43	10	255	41	4
6	20-May	43	11	252	33	4
7	19-May	42	8	241	38	3
8	18-May	41	11	221	38	4
9	15-May	42	9	272	42	4
10	14-May	43	13	272	37	5
11	13-May	44	14	298	35	5
12	12-May	43	20	308	43	9
13	11-May	46	37	367	31	11
14	8-May	46	42	340	36	15
15	7-May	44	16	343	41	6
16	6-May	44	20	380	42	8
17	5-May	42	8	257	33	3
18	4-May	42	9	291	40	3
19	30-Apr	41	7	285	35	2
20	29-Apr	42	9	319	41	4
21	28-Apr	42	15	317	53	8
22	27-Apr	43	13	288	48	6
23	24-Apr	42	11	316	42	5
24	23-Apr	43	22	363	37	8
25	22-Apr	43	20	384	40	8
26	21-Apr	42	9	323	39	3
27	20-Apr	41	13	267	42	5
28	17-Apr	42	27	344	34	9
29	16-Apr	41	20	409	48	9
30	15-Apr	41	12	394	40	5
31	13-Apr	40	13	297	34	5
32	10-Apr	40	11	289	40	4
33	9-Apr	40	13	308	32	4
34	8-Apr	40	17	329	35	6
35	7-Apr	38	10	253	33	3
36	6-Apr	38	16	324	23	4
37	2-Apr	38	14	299	28	4
38	1-Apr	37	20	354	21	4
39	30-Mar	34	14	260	46	7
40	27-Mar	36	20	263	40	8
41	25-Mar	37	12	381	38	4
42	24-Mar	37	12	320	31	4
43	23-Mar	35	12	270	37	4
44	20-Mar	37	9	353	38	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
26-May	2,408c	11c	0.46
25-May	2,397c	14c	0.60
22-May	2,383c	32c	1.35
21-May	2,351c	14c	0.59
20-May	2,337c	49c	2.13
19-May	2,288c	56c	2.50
18-May	2,232c	69c	3.00
15-May	2,301c	49c	2.10
14-May	2,351c	27c	1.13
12-May	2,378c	123c	4.91
11-May	2,500c	81c	3.35
07-May	2,419c	57c	2.41
06-May	2,362c	67c	2.94
05-May	2,295c	13c	0.57
04-May	2,308c	50c	2.23
30-Apr	2,258c	31c	1.36
29-Apr	2,289c	24c	1.02
28-Apr	2,312c	15c	0.67
24-Apr	2,297c	73c	3.08
23-Apr	2,370c	13c	0.53
22-Apr	2,357c	66c	2.89
21-Apr	2,291c	8c	0.33
17-Apr	2,299c	70c	3.12
16-Apr	2,229c	29c	1.26
15-Apr	2,258c	0	0

Stock Checklist

Price is below from 52 week high low average: 42%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView